HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $12,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -47.1% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $17,000 | +240.0% | 1,000 | +400.0% | 0.00% | – |
| Q2 2015 | $5,000 | -88.1% | 200 | -96.2% | 0.00% | -100.0% |
| Q2 2013 | $42,000 | – | 5,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |